190 related articles for article (PubMed ID: 16115774)
1. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds.
Aguirre G; Boiani L; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Möller M; Thomson L; Tórtora V
Bioorg Med Chem; 2005 Dec; 13(23):6324-35. PubMed ID: 16115774
[TBL] [Abstract][Full Text] [Related]
2. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
3. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II.
Aguirre G; Cerecetto H; Di Maio R; González M; Porcal W; Seoane G; Ortega MA; Aldana I; Monge A; Denicola A
Arch Pharm (Weinheim); 2002 Jan; 335(1):15-21. PubMed ID: 11933675
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
[TBL] [Abstract][Full Text] [Related]
5. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S
Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues.
Pozas R; Carballo J; Castro C; Rubio J
Bioorg Med Chem Lett; 2005 Mar; 15(5):1417-21. PubMed ID: 15713399
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
8. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Vicente E; Duchowicz PR; Benítez D; Castro EA; Cerecetto H; González M; Monge A
Bioorg Med Chem Lett; 2010 Aug; 20(16):4831-5. PubMed ID: 20634064
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
10. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies.
Aguirre G; Boiani L; Boiani M; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Piro OE; Castellano EE; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2005 Dec; 13(23):6336-46. PubMed ID: 16202608
[TBL] [Abstract][Full Text] [Related]
11. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H
Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
[TBL] [Abstract][Full Text] [Related]
13. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Caterina MC; Perillo IA; Boiani L; Pezaroglo H; Cerecetto H; González M; Salerno A
Bioorg Med Chem; 2008 Mar; 16(5):2226-34. PubMed ID: 18083035
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).
Schvartzapel AJ; Zhong L; Docampo R; Rodriguez JB; Gros EG
J Med Chem; 1997 Jul; 40(15):2314-22. PubMed ID: 9240347
[TBL] [Abstract][Full Text] [Related]
15. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
[TBL] [Abstract][Full Text] [Related]
16. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of the trypanocidal action of nifurtimox and other nitro-derivatives on Trypanosoma cruzi].
Docampo R; Stoppani AO
Medicina (B Aires); 1980; 40 Suppl 1():10-6. PubMed ID: 6779074
[No Abstract] [Full Text] [Related]
18. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
[TBL] [Abstract][Full Text] [Related]
19. Designing novel antitrypanosomal agents from a mixed graph-theoretical substructural approach.
Planche AS; Scotti MT; Emerenciano Vde P; López AG; Pérez EM; Uriarte E
J Comput Chem; 2010 Mar; 31(4):882-94. PubMed ID: 19618411
[TBL] [Abstract][Full Text] [Related]
20. Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides.
Tonin LT; Panice MR; Nakamura CV; Rocha KJ; dos Santos AO; Ueda-Nakamura T; da Costa WF; Sarragiotto MH
Biomed Pharmacother; 2010 Jul; 64(6):386-9. PubMed ID: 20382497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
